Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study - Grace Forde; Kimberly Becker Ifantides; Angeli Mayadev; Atul T. Patel; Christopher Rhyne; Theodore Brown; Ritu Singh; Mariana Nelson; Ahunna Ukah; Simona Battucci; Benjamin M. Brucker (Toxicon, 2026)